Clinical trial · Observational
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer and Its Relation With Disease Stages, Pathological Types and Grading
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objective: Calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types and grading. Patients and methods: 100 cases of endometrial cancer will be included in the study, recruited from Alexandria university hospital gyne-oncology unit. Surgical staging, histopathological examination and immunohistochemistry of p53 were done to all cases to calculate the incidence of P53 immunohistochemistry abnormal staining in endometrial cancer and to identify its relation with disease stages, pathological types, grading. Keywords: P53 immunohistochemistry, endometrial cancer, clinicopathological relation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- p53 immunohistochemistry
- timeFrame
- 1 month
- description
- Incidence of abnormal staining of p53 in endometrial cancer
- measure
- Relation of p53 abnormal staining with disease stages
- timeFrame
- 1month
- description
- Relation of p53 abnormal staining with disease stages
- measure
- Relation of p53 abnormal staining with disease pathological types
- timeFrame
- 1 month
- description
- Relation of p53 abnormal staining with disease pathological types
- measure
- Relation of p53 abnormal staining with disease pathological grades
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * endometrial cancer patients Exclusion Criteria: * patients unfit for surgery
References
Publications (0)
Data not yet available